EcoDrugPlus

Glutamate Receptor, Ionotropic, Ampa 1a

Ensembl ID : ENSOTSG00005016706
Gene Symbol: GRIA1A
1 Cross references
251 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 1b

Ensembl ID : ENSOTSG00005019814
Gene Symbol: GRIA1B
1 Cross references
242 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 3a

Ensembl ID : ENSOTSG00005027807
Gene Symbol: GRIA3A
1 Cross references
245 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 4b

Ensembl ID : ENSOTSG00005044976
Gene Symbol: GRIA4B
1 Cross references
243 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 4b

Ensembl ID : ENSOTSG00005004839
Gene Symbol: GRIA4B
1 Cross references
243 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 4b

Ensembl ID : ENSOTSG00005036677
Gene Symbol: GRIA4B
1 Cross references
243 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 1a

Ensembl ID : ENSOTSG00005010180
Gene Symbol: GRIN1A
1 Cross references
199 Possible Orthologues:

Glutamate Receptor, Metabotropic 2b

Ensembl ID : ENSOTSG00005033031
Gene Symbol: GRM2B
1 Cross references
200 Possible Orthologues:

Glutamate Receptor, Metabotropic 3

Ensembl ID : ENSOTSG00005025029
Gene Symbol: GRM3
1 Cross references
207 Possible Orthologues:

Glutamate Receptor, Metabotropic 3

Ensembl ID : ENSOTSG00005012042
Gene Symbol: GRM3
1 Cross references
207 Possible Orthologues:

Glutamate Receptor, Metabotropic 5b

Ensembl ID : ENSOTSG00005001811
Gene Symbol: GRM5B
1 Cross references
212 Possible Orthologues:

Glutaminase Kidney Isoform, Mitochondrial-Like

Ensembl ID : ENSOTSG00005042156
Gene Symbol: LOC112253954
3 Cross references
220 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).